The role of the Health Products Regulatory Authority (HPRA) is to protect and enhance public and animal health by regulating medicines, medical devices and other health products.

Under our enforcement programme: pg. 20 – We processed the detention of 956,263 dosage units (including tablets, capsules and vials) of falsified and other illegal medicines in 2022, compared to 1,604,589 dosage units in 2021. The products detained included sedatives (26%), anabolic steroids (23%), erectile dysfunction medicines (9%) and analgesics (7%). 5,171 enforcement cases were initiated, compared to 10,596 in the previous year.